
FDA finalized the switch to a uniform 12-digit NDC format effective March 2033. Here's what's changing, how the transition works, and what it means for pharmacy.

The FDA has approved the first generic version of Flovent HFA (fluticasone propionate) inhaler for asthma. Here's what healthcare providers need to know.

NCPA's new multi-million-dollar campaign highlights the personalized care of independent pharmacies over chain and mail-order services.

A Nature Medicine study tested ChatGPT Health on medical triage using an outdated model. Here's why the findings, while important, deserve more context.

Tennessee's SB 2040 would ban PBMs from owning pharmacies. CVS threatens to close all 134 locations. Here's what pharmacists need to know.

Eli Lilly launches Zepbound KwikPen, a multi-dose device delivering a full month of tirzepatide. Here's what pharmacists need to know about access and pricing.

RedSail Technologies acquires PrimeRx pharmacy management software, expanding its network to 16,000 pharmacies. Here's what healthcare providers need to know.

FDA approves YUVEZZI, the first combination eye drop for presbyopia. Learn how this dual-agent treatment works and what it means for pharmacy practice.

Explore how zoster vaccination can reduce cardiovascular, dementia, and mortality risks in older adults with herpes zoster.

Learn about the Uniform MPJE exam launching in 2026! NABP's new multi-state pharmacy jurisprudence test designed to streamline pharmacist licensure and portability.

The FDA is intensifying actions against non-FDA-approved GLP-1 drugs. Learn about the implications for pharmacists and healthcare professionals.

FDA eliminates mandatory safety program for clozapine, citing access concerns while acknowledging ongoing neutropenia risk for patients.